JP2014524475A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524475A5
JP2014524475A5 JP2014527282A JP2014527282A JP2014524475A5 JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5 JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5
Authority
JP
Japan
Prior art keywords
amino
pyridazin
phenyl
oxo
dihydropyrimido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527282A
Other languages
English (en)
Japanese (ja)
Other versions
JP5993010B2 (ja
JP2014524475A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/051980 external-priority patent/WO2013028818A1/en
Publication of JP2014524475A publication Critical patent/JP2014524475A/ja
Publication of JP2014524475A5 publication Critical patent/JP2014524475A5/ja
Application granted granted Critical
Publication of JP5993010B2 publication Critical patent/JP5993010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527282A 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用 Active JP5993010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161526525P 2011-08-23 2011-08-23
US61/526,525 2011-08-23
PCT/US2012/051980 WO2013028818A1 (en) 2011-08-23 2012-08-23 Pyrimido- pyridazinone compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2014524475A JP2014524475A (ja) 2014-09-22
JP2014524475A5 true JP2014524475A5 (https=) 2015-10-15
JP5993010B2 JP5993010B2 (ja) 2016-09-14

Family

ID=46829884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527282A Active JP5993010B2 (ja) 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用

Country Status (14)

Country Link
US (5) US8729079B2 (https=)
EP (4) EP4327886A3 (https=)
JP (1) JP5993010B2 (https=)
CN (2) CN108707151B (https=)
BR (1) BR112014003981A2 (https=)
CA (1) CA2846187A1 (https=)
DK (2) DK3392252T3 (https=)
ES (2) ES2690971T3 (https=)
FI (1) FI3392252T3 (https=)
HU (1) HUE065564T2 (https=)
IL (1) IL231082A (https=)
MX (1) MX361458B (https=)
PL (1) PL2748166T3 (https=)
WO (1) WO2013028818A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2748166T3 (pl) * 2011-08-23 2019-05-31 Asana Biosciences Llc Związki pirimido-pirydazynonowe oraz ich zastosowanie
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
WO2018187294A1 (en) * 2017-04-03 2018-10-11 Asana Biosciences, Llc Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof
CN118105392A (zh) * 2017-04-28 2024-05-31 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
CN111961035B (zh) * 2019-05-20 2022-11-01 南京科技职业学院 一类含有羟基异喹啉类结构的化合物、药物组合物以及其应用
CN114174298B (zh) * 2019-08-14 2023-08-01 正大天晴药业集团南京顺欣制药有限公司 哒嗪酮并嘧啶类衍生物及其医药用途
CN113583026B (zh) * 2020-04-30 2024-06-14 杭州英创医药科技有限公司 一类含有稠合三环结构的化合物
TW202202498A (zh) * 2020-07-01 2022-01-16 大陸商四川海思科製藥有限公司 一種並環雜環衍生物及其在醫藥上的應用
TW202340202A (zh) * 2021-12-22 2023-10-16 美國加利福尼亞大學董事會 Gtp酶抑制劑及其用途
KR20240151808A (ko) 2022-02-23 2024-10-18 테바 파마슈티컬스 인터내셔널 게엠베하 구사시티닙의 고체 상태 형태
US20260055079A1 (en) * 2022-04-01 2026-02-26 Azkarra Therapeutics, Inc. Phthalazinone compounds as parp7 inhibitors
WO2025020171A1 (en) 2023-07-27 2025-01-30 Libertas Bio, Inc. Crystalline forms of a jak/syk inhibitor
TW202510870A (zh) 2023-07-27 2025-03-16 美商自由生物有限公司 Jak/syk抑制劑之組合物及固體形式

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756508A (fr) 1969-09-24 1971-03-01 Takeda Chemical Industries Ltd Derives de pyrimidopyridazine
CA1004223A (en) * 1972-05-12 1977-01-25 Theodor Denzel Amino derivatives of pyrido(2,3-d)pyridazine carboxylic acids and esters
JPS4948695U (https=) 1972-07-29 1974-04-27
JPS50101387A (https=) * 1974-01-16 1975-08-11
CA1052046A (en) 1974-01-21 1979-04-03 American Cyanamid Company Unsymmetrically substituted 1,4-dioxane-2,5-diones
US5369086A (en) 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
JPH0948695A (ja) 1995-08-02 1997-02-18 Toshiba Ceramics Co Ltd シリコン単結晶の製造方法
JP2002504550A (ja) 1998-02-25 2002-02-12 ファルマシア・アンド・アップジョン・カンパニー 抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体
SK287270B6 (sk) 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds
DE60225127T2 (de) 2001-04-30 2009-02-19 Glaxo Group Ltd., Greenford Kondensierte pyrimidine als antagonisten des corticotropin releasing factor (crf)
WO2003075828A2 (en) 2002-03-11 2003-09-18 Zetiq Technologies Ltd. Compounds useful in the treatment of cancer
HRP20050089B1 (hr) 2002-07-29 2015-06-19 Rigel Pharmaceuticals Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
CA2518465A1 (en) 2003-03-25 2004-10-14 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2005012294A1 (en) 2003-07-30 2005-02-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
WO2005080377A1 (ja) 2004-02-20 2005-09-01 Kirin Beer Kabushiki Kaisha TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
WO2006035067A2 (en) 2004-09-30 2006-04-06 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-heterocyclyl pyrimidines
WO2006066361A1 (en) 2004-12-24 2006-06-29 The University Of Queensland Method of treatment or prophylaxis
CN101189234B (zh) 2005-03-25 2011-08-17 泰博特克药品有限公司 Hcv的杂二环抑制剂
US8030318B2 (en) 2005-03-25 2011-10-04 Tibotec Pharmaceuticals Ltd. Fused bicyclic inhibitors of HCV
KR20080000584A (ko) 2005-04-29 2008-01-02 얀센 파마슈티카 엔.브이. 카나비노이드 수용체 길항제로서의 벤조트리아졸 유도체
WO2007063934A1 (ja) * 2005-12-02 2007-06-07 Mitsubishi Tanabe Pharma Corporation 脂環式複素環化合物
WO2007082131A1 (en) 2006-01-09 2007-07-19 Bristol-Myers Squibb Company Process for the preparation of hydroxy substituted heterocycles
CA2651072A1 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
GB0625196D0 (en) 2006-12-18 2007-01-24 7Tm Pharma As Modulators of cannabinoid receptor
ES2548353T3 (es) * 2006-12-28 2015-10-15 Abbvie Inc. Inhibidores de poli(ADP-ribosa)polimerasa
SG179418A1 (en) 2007-03-14 2012-04-27 Exelixis Patent Co Llc Inhibitors of the hedgehog pathway
TW200938542A (en) 2008-02-01 2009-09-16 Irm Llc Compounds and compositions as kinase inhibitors
BRPI0919488A2 (pt) 2008-09-30 2015-12-01 Astrazeneca Ab composto, uso de um composto, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
TW201016676A (en) 2008-10-03 2010-05-01 Astrazeneca Ab Heterocyclic derivatives and methods of use thereof
EA022417B1 (ru) 2008-10-21 2015-12-30 Саймабэй Терапевтикс, Инк. Арильные агонисты рецептора gpr120 и их применение
MX2012004846A (es) * 2009-10-29 2012-10-05 Genosco Inhibidores de cinasa.
US20110152243A1 (en) * 2009-12-23 2011-06-23 Abbott Laboratories Novel thienopyrrole compounds
WO2012058671A1 (en) 2010-10-31 2012-05-03 Endo Pharmaceuticals Inc. Substituted quinazoline and pyrido-pyrimidine derivatives
PL2748166T3 (pl) * 2011-08-23 2019-05-31 Asana Biosciences Llc Związki pirimido-pirydazynonowe oraz ich zastosowanie
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
CN118105392A (zh) * 2017-04-28 2024-05-31 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型

Similar Documents

Publication Publication Date Title
JP2014524475A5 (https=)
JP2022531801A5 (https=)
JP2019517596A5 (https=)
AU2016352813B2 (en) Novel pyrazolo pyrimidine derivatives
AU2013210438B2 (en) Pyrazine carboxamide compound
KR20230024251A (ko) 신규 plk1 분해 유도 화합물
RU2018124289A (ru) Применения пиримидо-пиридазинонов для лечения рака
ES2946274T3 (es) Inhibidores de TRPC6
JP7366994B2 (ja) 自己免疫疾患治療用の新規ピペラジン化合物
WO2019126081A1 (en) Amide substituted indole compounds useful as tlr inhibitors
AU2015304883A1 (en) Aminopyrimidinyl compounds as JAK inhibitors
ES3034264T3 (en) 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis
RU2013102881A (ru) Новые конденсированные пиримидиновые производные для ингибирования тирозинкиназной активности
RU2014154397A (ru) Соединения тетрагидропиразолопиримидина
EP2925322A1 (en) Inhibitors of the renal outer medullary potassium channel
KR102646850B1 (ko) 안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
KR20140138851A (ko) 류코트리엔 생성 억제를 위해 기타 활성제와 병용된 벤조디옥산
KR20150127721A (ko) 디하이드로피리다진-3,5-디온 유도체
WO2024059808A1 (en) Wee1 inhibitors and methods for treating cancer
JP2024009891A (ja) T型カルシウムチャネル阻害剤
RU2666894C2 (ru) Производные пиперидинмочевины
AU2023330130A1 (en) Compounds and methods for modulating her2
RU2006146621A (ru) Производные нафталина, пригодные в качестве лигандов рецепторов 3 гистамина
RU2472781C2 (ru) Новые соединения 707 и их применение
WO2024222726A1 (zh) 细胞周期蛋白依赖性激酶12/13的降解剂、组合物及其应用